Lymphocyte activation results in the transcription of a number of gene products that mobilize and maintain a functional immune response. Such gene products regulate cellular differentiation, effector function, and clonal expansion of the responding lymphocyte population. One such gene product is Fas (CD95), a cell surface protein known to induce apoptosis in activated lymphocytes upon binding to its cognate ligand (FasL). The essential roles of Fas and FasL in the maintenance of peripheral self-tolerance underscore their prominence as homeostatic regulators of the immune system (reviewed in reference 41). Within the T-cell compartment, Fas is expressed on immature thymocytes, but does not appear to be involved in thymic deletion (13, 17) . Fas expression on resting peripheral blood lymphocytes is low to absent (26, 37, 41, 44) . Primary T-cell activation results in upregulation of fas mRNA and protein followed by the gradual acquisition of sensitivity to Fas-mediated apoptosis (37, 44) . Although the regulation of Fas-mediated apoptosis is complex, involving assembly of the intracellular proteins necessary to initiate the apoptotic cascade (7, 40) and an absence or low abundance of inhibitory proteins, such as FAP-1 (53), FLIP (22) , bcl-2, and bcl-x L (6, 23, 25) , Fas receptor cross-linking is fundamentally required (24) . Fas expression is maintained on activated lymphocytes for several weeks (44) , and upon secondary exposure to antigen, FasL is upregulated (1, 14, 26) . Autocrine or paracrine interactions of Fas and FasL result in the apoptotic elimination of responding CD4 ϩ lymphocytes, a process termed "activation-induced cell death" (AICD) (1, 14, 26) . AICD can also be induced in CD4 ϩ T-cell lines by T-cell receptor (TCR) engagement or pharmacological mimics of TCR signaling, such as anti-CD3 antibodies or phorbol myristate acetate (PMA) plus ionomycin (P/I), respectively. In direct contrast, activated CD8 ϩ T cells do not appear to undergo apoptosis as a result of Fas ligation, but rather are stimulated to undergo clonal expansion by reverse signaling through FasL (59) . Thus, while Fas appears to be equivalently upregulated in both CD4 ϩ and CD8 ϩ T cells upon activation (37) , the signals transduced by both Fas and FasL have dissimilar biological effects on the two lymphocyte subsets.
The transcriptional machinery controlling Fas expression is largely unknown. Genomic organization studies showed that human fas is a single-copy gene containing nine exons and eight introns, spanning approximately 25 kb (5) . Sequences proximal to the Fas translational start site have a relatively high GC content (61%) between Ϫ590 and Ϫ1, a number of CpG dinucleotides (28 CpGs between Ϫ590 and Ϫ1), and an absence of conventional TATA and CAAT boxes (5) . These are properties characteristic of a class of polymerase II-dependent promoters that include housekeeping genes (reviewed in reference 3) and other members of the tumor necrosis factor (TNF)-nerve growth factor receptor superfamily (28, 51, 52, 54) . Although Fas is constitutively expressed on a variety of nonhematopoietic cells and hematopoietic cell lines (33, 43) , multiple reports have documented Fas inducibility in response to such stimuli as UV irradiation, viral infection, wild-type p53, hypoxia, and chemotherapeutic agents (2, 34, 39, 45, 47, 61) . To date, however, the molecular events regulating constitutive and inducible fas expression have not been elucidated.
In the present study, we have investigated the transcriptional machinery required for activation-dependent induction of Fas expression in the CD4 ϩ Jurkat T-cell line. Although constitutively expressed on Jurkat cells, Fas can be markedly upregulated by P/I activation. Using deletion constructs of the fas promoter in luciferase reporter assays, we demonstrate the presence of a previously unrecognized, activation-responsive 47-bp sequence containing a composite binding site for both Sp1 and NF-B transcription factors. Characterization of this noncanonical site (located at positions Ϫ295 to Ϫ286) by electrophoretic mobility shift assay (EMSA) and supershift analyses revealed that Sp1 was constitutively bound to this site in untreated Jurkat cells, while p50-p65 NF-B heterodimers were bound after P/I activation. Site-directed mutagenesis of the critical guanine nucleotides in the B-Sp1 site, as well as inhibition of IB degradation or NF-B translocation, inhibited inducible Fas transcription. Taken together, our results indicate a critical requirement for NF-B translocation to the B-Sp1 site at positions Ϫ295 to Ϫ286 in activation-driven fas promoter induction. TC) by PCR to generate a 1.72-kb product. This PCR product was then subcloned into the pcR2 expression vector (Invitrogen, San Diego, Calif.) and digested with EcoRI, and the insert was shuttled into pGEM7ϩ (Promega) (pFPR7ϩ). A partial XhoI digest and complete HindIII digest of pFPR7ϩ were made to insert the 1.7-kb fragment into the pGL2Basic luciferase reporter construct (Promega) in either orientation. The final constructs, FPR1-Luc(ϩ) and FPR1-Luc(Ϫ), spanning the region (1739 to Ϫ19) upstream of the fas ATG were sequenced to verify orientation and identity.
The thymidine kinase promoter reporter construct tk-Luc was generated by subcloning the BglII-HindIII fragment of the thymidine kinase promoter from pRL-tk (Promega) into pGEM-11, followed by insertion of the SacI-HindIII fragment into pGL2B. The ⌬5/⌬6-tk-Luc reporter was constructed by subcloning the SacI fragment from FPR-Luc(ϩ) into tk-Luc, digesting it with XhoI-PstI, treating it with a Klenow fragment to fill recessed ends, and performing blunt end ligation.
Deletion constructs were generated as follows. ⌬5-Luc (Ϫ460 to Ϫ19) is the product of a religated XhoI digest of FPR-Luc(ϩ); ⌬6-Luc (Ϫ236 to Ϫ19) is the product of a religated complete SacI digest of FPR-Luc(ϩ). Constructs within the ⌬5-Luc region were generated by PCR with the following oligonucleotides, digested with KpnI (underlined)-HindIII (double underlined), and subcloned directly into pGL2B: ⌬5. ; mutated nucleotides are in lowercase) by using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, Calif.) according to the manufacturer's recommendations. All constructs were confirmed by dideoxy sequencing with vector and internal primers.
Luciferase reporters containing B-Sp1 concatemers were constructed with oligonucleotides having two copies of the element at position Ϫ295 to position Ϫ286. These oligonucleotides were synthesized with either KpnI (underlined) or SacI (double underlined) 3Ј overhangs (forward, 5ЈCGGGCGTTCCCAAAAAG GGCGTTCCCGAGCT and reverse, 5ЈCGGGAACGCCCTTTTTGGGAACG CCCGGTAC; forward, 5ЈCGGGCGTTCCCAAAAAGGGCGTTCCCGGTAC and reverse, 5ЈCGGGAACGCCCTTTTTGGGAACGCCCGAGCT). The corresponding 5Ј KpnI-3Ј SacI or 5Ј SacI-3Ј KpnI oligonucleotides were annealed (10 min at 85°C and then cooled to room temperature), and timed ligations were prepared with T4 ligase with various ratios of the double-stranded primers. Aliquots of the reaction mixtures were heated to 75°C for 10 min to inactivate the ligase before subcloning into the KpnI-SacI-digested tk-Luc vector (see above). Various clones were screened by sequence analysis to determine the number of B-Sp1 elements present. The resultant constructs containing two, four, and six copies of the B-Sp1 site were used for transient transfection and reporter assays.
Transient transfections and reporter assays. A DEAE-dextran-chloroquine mixture was used for transient transfection of Jurkat cells. Briefly, 5 ϫ 10 6 to 7.5 ϫ 10 6 exponentially growing cells were washed and resuspended in 1 ml of transfection solution (RPMI plus 250 g of DEAE-dextran per ml, 0.1 M Tris [pH 7.2], and 0.1 mM chloroquine) together with 10 g of reporter construct and 10 ng of the pRL-tk Renilla normalizing luciferase vector (Promega). The cells were incubated for 1.5 h at 37°C, washed, and plated in 10 ml of complete media. After a 20-h recovery, transfected cells were activated with P/I for 8 h. Cell extracts and luciferase reagents were prepared with the Promega Dual-Luciferase Reporter Assay System. Both firefly and Renilla luciferase activities were monitored with a luminometer (Turner Industries, Sunnyvale, Calif.). Normalized reporter activity is expressed as the firefly luciferase value divided by the Renilla luciferase value. Relative fold induction is calculated as the normalized reporter activity of the test sample divided by either the untreated FPR-Luc or ⌬5-Luc reporter construct, as indicated below. The Rous sarcoma virus promoter-driven IB␣ construct (RSV-IB␣) and vector control were obtained from Tse-Wa Tan (Baylor College of Medicine, Houston, Tex.).
Nuclear extract preparation, EMSAs, supershift analyses, and displacement studies. Nuclear extracts were prepared by a modified method of Dignam et al. (15) . In brief, 7.5 ϫ 10 6 Jurkat cells were washed in PBS and pelleted before resuspension in 200 l of cold buffer A (10 mM HEPES (pH 7.9), 50 mM NaCl, 1 mM dithiothreitol, 0.1 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride [PMSF] ) and incubated for 20 min on ice prior to the addition of 200 l of cold buffer B (buffer A with 0.1% Nonidet P-40). Cells were gently pipetted and returned on ice for another 20 min. Nuclei were pelleted (5,000 ϫ g, 2 min), washed in buffer A, and pelleted again, and nuclear proteins were extracted in 25 l of buffer D (400 mM NaCl, 20 mM HEPES (pH 7.9), 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol 1 mM PMSF). The tubes were iced for at least 30 min, followed by centrifugation at 4°C for 10 min. The supernatant was recovered, snap-frozen in liquid nitrogen, and stored at Ϫ80°C prior to use.
Probes used for EMSAs were radiolabeled by [␥-32 P]ATP end labeling with T4 polynucleotide kinase. Briefly, 30 g of the ⌬5-Luc plasmid was digested with XhoI, dephosphorylated with calf intestine phosphatase, and both enzymes were inactivated at 85°C for 10 min. An aliquot of the digest (7.5 g) was end labeled with [␥-32 P]ATP for 60 min before the kinase was inactivated at 75°C for 10 min. The end-labeled plasmid was then digested overnight with SacI, and the released probe A (Ϫ460 to Ϫ236) was gel purified as described previously (11) . The oligonucleotide probe B (Ϫ306 to Ϫ278; 5Ј Ϫ306 CTCCCCAACCCGGGCGTTC CCCAGCGAGG) or its mutated counterpart was annealed to the corresponding complementary sequence before 1 pmol was end labeled with [␥-32 P]ATP for 30 min. The labeled probe was purified from unincorporated nucleotides by using a Chroma Spin 10 column (Clonetech) following the manufacturer's instructions. The specific activities of all 32 P-labeled oligoprobes were routinely 5 ϫ 10 6 to 6 ϫ 10 6 cpm per pmol. Protein concentration was determined with the Bio-Rad protein assay reagent (Bio-Rad, Richmond, Calif.). For EMSAs, 6 g of nuclear extract was incubated in a total volume of 19 l of binding buffer [50 mM NaCl, 10 mM Tris (pH 7.9), 0.5 mM EDTA, 1 g of poly(dI-dC), and 5% glycerol] for 15 min at room temperature before 50,000 cpm of the indicated ␥-32 P-end-labeled probe was added for another 15 min. For competition assays, excess unlabeled oligonucleotides were preincubated for 15 min prior to the addition of the radiolabeled probe (50,000 cpm). For antibody-mediated supershift assays, extracts were preincubated with 1 l of either anti-p50, -p65, -c-Rel (Oncogene Research, Cambridge, Mass.) -relB, -p52, or -Sp1 (Santa Cruz Biotechnology, Santa Cruz, Calif.) antibodies at 4°C for 45 min before the addition of the radiolabeled probe. The reactions were loaded on a 4.5% polyacrylamide nondenaturing PAGE gel in 0.5ϫ Tris-borate-EDTA electrophoresed for 2.5 h at 100 V before drying and exposed to autoradiographic film.
For displacement studies, 4 footprinting units (fpu) of Sp1 (ϳ30 ng; Promega) was preincubated in a total volume of 19 l of binding buffer for 5 min prior to addition of 12,500 cpm of labeled probe B. After 15 min at room temperature, increasing amounts of recombinant p50 NF-B (Promega) subunits were added for an additional 15 min before the mixture was loaded on a 4.5% polyacrylamide PAGE gel as described above.
RESULTS

Expression of Fas mRNA and protein is upregulated in Jurkat cells by pharmacological agents that mimic T-cell activation.
While resting T cells express low to undetectable levels of the Fas protein (26, 37, 41, 44) , it is rapidly upregulated upon exposure to specific antigens, mitogens, cytokines, TCR antibodies, and various pharmacological agents such as P/I (6, 37, 44). The Jurkat T-cell line has an activated T-cell phenotype, in that it constitutively expresses cell surface Fas (Fig. 1A) . Because we were interested in the transcriptional mechanisms controlling Fas expression, we asked whether Fas could be upregulated in Jurkat cells upon activation. To this end, Jurkat cells were stimulated with P/I for various times, and mRNA and protein expression was determined with RPAs and FACS analyses, respectively. As shown in A 220-bp region in the Fas promoter is required for activation-dependent upregulation. To test the premise that activation-dependent Fas upregulation was modulated at the level of transcription, approximately 1.7 kb of the 5Ј region flanking the fas translational start site (nucleotides Ϫ1739 to Ϫ19) were isolated from a human placental genomic library and subcloned into the pGL2-Basic luciferase reporter vector in both orientations relative to the luciferase gene. The basal activity of the FPR1-Luc(ϩ) construct was first determined by transient transfections into various T-and B-cell lines, followed by extract preparations and luciferase activity measurements. As shown in Fig. 2A , the FPR1-Luc(ϩ) construct demonstrated basal activity in the Jurkat (13-fold over empty vector), Molt-4 (32-fold), and HSB (14-fold) T-cell lines. In B-cell lines, modest basal activity was observed only in Raji cells (fivefold over empty vector alone), but not in Daudi or Ramos cells. These results document that the 1.7-kb region upstream of the fas ATG contains a functional promoter operative in T-cell lines and certain B-cell lines.
To determine whether FPR1-Luc(ϩ) was responsive to activation, transiently transfected Jurkat cells were treated with P/I as described in Materials and Methods, and the relative luciferase activities of untreated and P/I-stimulated cells were compared. As shown in compared to the basal activity of unstimulated Jurkat cells. The fas promoter is orientation dependent, since FPR1-Luc(Ϫ) was inactive in both resting and stimulated cells. To more precisely map the fas promoter region(s) responsive to P/I activation, two deletion constructs containing the sequences from Ϫ460 to Ϫ19 (⌬5-Luc) and Ϫ240 to Ϫ19 (⌬6-Luc) were prepared as described in Materials and Methods. As shown in Fig. 2B , P/I inducibility of the fas promoter was maintained when the sequences between Ϫ1739 and Ϫ460 were deleted. However, when sequences between Ϫ460 and Ϫ240 were deleted, P/I-induced upregulation was virtually absent. As shown, FPR1-Luc(ϩ) and ⌬5-Luc were upregulated 17-and 15-fold after P/I treatment, respectively, while the ⌬6-Luc construct was upregulated by less than 4-fold. Interestingly, no differences were noted in the activity of these constructs in unstimulated Jurkat cells, suggesting that the fas promoter sequences between Ϫ460 and Ϫ240 are critically important for activationdependent, but not basal, transcription. Sequence analysis within this region demonstrated the presence of consensus elements for several transcription factors, including AP-2, GAS, NF-B, and NF-AT.
To investigate whether the 220-bp region between Ϫ460 and Ϫ240 contained enhancer elements responsive to P/I activation, this region was subcloned proximal to a thymidine kinase promoter in a luciferase reporter construct (⌬5/⌬6-tk-Luc), and transient transfection reporter assays were carried out. As shown in Fig. 2B , the ⌬5/⌬6-tk-Luc construct was highly inducible by P/I (12-fold relative to tk-Luc), at levels comparable to that of the native Fas promoter. These results suggest that the fas promoter region between Ϫ460 and Ϫ240 contains enhancer element(s) necessary for activation responsiveness.
To analyze whether transcription factors may be involved in the activation-dependent upregulation of the fas promoter within this region, EMSA analyses were carried out. Nuclear extracts, prepared from unactivated and P/I-stimulated Jurkat cells, were incubated with a 32 P-labeled probe spanning the fas promoter region between Ϫ460 and Ϫ236 (probe A). A time course analysis revealed the presence of two complexes binding to this region. An upper complex, designated C2, was constitutively bound in unactivated Jurkat extracts throughout the course of activation (Fig. 2C, lanes 1 to 3) . A second lower complex, designated C1, bound only upon P/I activation (Fig.  2C, Lane 2) . To determine the nature of the C1 and C2 complexes, cold-target competition was carried out with 25-fold excesses of the Sp1, NF-B, and AP-1 consensus elements. As shown (Fig. 2C, lane 5) , C2 binding was inhibited by Sp1-specific oligonucleotides, indicating the presence of an Sp1-like transcription factor at this site. C1 binding was specifically competed by using B consensus oligonucleotides derived from the human immunodeficiency virus long terminal repeat (HIV LTR) (Fig. 2C, lane 6 ). Other cold-target consensus elements tested, including AP-1, AP-2, NF-ATp, and GAS, were incapable of inhibiting either C1 or C2 binding (Fig. 2C , lane 7, and data not shown). Thus, in the promoter region required for activation-dependent Fas upregulation, Sp1 bound constitutively, while NF-B complex formation occurred only in response to stimulation.
Activation-dependent Fas promoter induction requires nucleotides ؊306 to ؊260. To analyze the region between Ϫ460 and Ϫ240 in further detail, sequential deletions of ⌬5-Luc spanning 40-to 60-bp intervals were generated by PCR. The precise sequences contained in the various constructs are shown in Fig. 3A . Basal and inducible promoter activities in transiently transfected, unactivated, and P/I-stimulated Jurkat cells, respectively, are shown in Fig. 3B . Deletion of nucleotides Ϫ460 to Ϫ306 and Ϫ259 to Ϫ240 had little effect on the activation-dependent induction of the fas promoter (⌬5 to ⌬5.7, ⌬5.8 to ⌬6), ruling out the contribution of the consensus NF-B sites located at Ϫ421 to Ϫ412 and Ϫ252 to Ϫ243, the GAS element at Ϫ394 to Ϫ386, and the NF-ATp-AP-2 site at positions Ϫ358 to Ϫ345. When nucleotides Ϫ306 to Ϫ260 (⌬5.7 to ⌬5.8) were deleted, however, inducible reporter activity was reduced to that observed with the ⌬6 construct. The sequences between Ϫ306 and Ϫ260 were devoid of any mapped transcription factor consensus sites, except for a Blike motif present at positions Ϫ295 to Ϫ286. This motif contains the sequence GGGCGTTCCC and differs from the derived consensus B p50-p65 heterodimer motif GGGRNNY YCC (20, 30, 48) at position 4 (change of R to C). Notably, however, the critical G 1-3 nucleotides necessary for p50 binding are maintained. Comparison of this motif to a consensus Sp1 site, KRGGCGKRRY (35) , also revealed homology at 8 of 10 residues, indicating a possible interaction with this transcription factor. Taken together with results from our previous studies showing that complexes that could be competed with Sp1 and NF-B oligonucleotides bound to the fas promoter region at Ϫ406 to Ϫ236, it seemed likely that these transcription factors, acting alone or in combination, might be required for activation-dependent fas promoter induction.
Sp1 and NF-B conjointly bind at the B-Sp1-like motif (؊295 to ؊286) during activation-driven fas promoter induction. To further investigate the transcription factors involved in fas promoter upregulation in P/I-activated Jurkat cells, EMSA analyses of nuclear extracts were performed with a 29-bp probe spanning the noncanonical B-Sp1-like motif (Ϫ306 to Ϫ278; probe B). In concert with our previous observations with probe A, spanning nucleotides Ϫ460 to Ϫ236 (Fig. 2C) , we observed constitutive binding of the C2 complex in both unactivated and P/I-stimulated extracts and inducible binding of the C1 complex upon activation (Fig. 4A) . C1 was induced de novo within 15 min of P/I addition (Fig. 4A, lane 2) and persisted for up to 2 h postactivation (Fig. 4A, lane 5) . The specificities of C1 and C2 binding to probe B were first demonstrated by cold-competition assays using excess unlabeled probe B (Fig. 4A, lane  9) . Jurkat extracts were coincubated with radiolabeled probe B and 25-fold excesses of either unlabeled AP-1-or NF-ATspecific oligonucleotides or a mutated probe B (GGG to TTT [see below]). Under these conditions, no displacement was observed in either C1 or C2 binding complexes (Fig. 4A, lanes  7, 8, and 10 ). To investigate Sp1-NF-B binding to probe B, Jurkat extracts were incubated with labeled probe B and increasing concentrations of unlabeled NF-B consensus oligonucleotides. With a 25-fold excess, NF-B oligonucleotides effectively competed the inducible C1 complex, but not the C2 complex. However, at 100-fold excess, both C2 and nonspecific binding were inhibited (Fig. 4A, lanes 11 to 12) . Increasing concentrations of Sp1 oligonucleotides, on the other hand, specifically competed the constitutive C2 complex, but not the inducible C1 binding (Fig. 4A, lanes 13 and 14) .
We next addressed whether extracts from P/I-activated Jurkat cells bound to probe B could be supershifted by using antibodies against various NF-B-Rel family members, including p50, p52, p65, c-Rel, and RelB. As shown in Fig. 4B , the inducible C1 complex was supershifted with antibodies against p50, p65, and to a lesser extent, c-Rel, indicating the presence of these heterodimers in the shifted complex (Fig. 4B, lanes 2  to 4) . No such shifted complexes were observed in extracts from unactivated Jurkat cells lacking the inducible C1 complex (data not shown). Antibodies against Sp1, on the other hand, shifted the constitutive C2 complex in both activated (Fig. 4B , lanes 7 and 8) and unactivated Jurkat extracts (data not shown). These results imply that Sp1 is bound to the B-Sp1 site at Ϫ295 to Ϫ286 during normal basal transcription, whereas NF-B p50-p65 heterodimers occupy the B-Sp1 site during activation-driven fas promoter induction.
Mutually exclusive binding of Sp1 versus NF-B at nucleotides ؊295 to ؊286. To assess whether binding of Sp1 and NF-B to the Ϫ295 to Ϫ286 site in the fas promoter occurs concurrently or as a mutually exclusive event, EMSA analyses were performed with probe B with recombinant Sp1 and increasing amounts of recombinant p50. Consistent with our observations using extracts from unactivated Jurkat cells, a single complex is observed when probe B is mixed with Sp1 alone (Fig. 4C, lane 2) . As increasing amounts of recombinant p50 are added, however, the intensity of the Sp1 complex is decreased, with a concomitant increase in the lower p50 binding complex (Fig. 4C, lanes 3 to 6) . These results indicate that the fas promoter region at Ϫ295 to Ϫ286 contains a single B-Sp1 binding motif to which either Sp1 or NF-B is exclusively bound. Upon cellular activation, constitutively bound Sp1 is likely displaced by NF-B to drive fas promoter upregulation.
NF-B recruitment regulates activation-dependent Fas promoter induction. Although the above in vitro analyses document that NF-B heterodimers are rapidly recruited to the fas promoter region controlling activation-dependent induction, these studies do not address the functional consequences of the effects of NF-B recruitment on fas promoter activity. To investigate the role of NF-B recruitment in activation-driven fas upregulation, the effects of various inhibitors of NF-B function were examined. Jurkat cells transiently transfected with the ⌬5-Luc reporter were pretreated with two pharmacological inhibitors of NF-B and then activated with P/I, and luciferase activity was determined. As shown in Fig. 5A , cyclosporin A pretreatment of Jurkat cells completely prevented P/I-dependent upregulation of the fas promoter. Because this calcineurin inhibitor can inhibit NF-AT translocation and disrupt Ca 2ϩ signals leading to NF-B induction (36) , the fungal metabolite gliotoxin, a specific inhibitor of IB-␣ degradation and NF-B translocation, was also used (46) . Gliotoxin, but not the inactive gliotoxin derivative bis-dethio-bis(methylthio) gliotoxin, completely abolished P/I inducibility of the ⌬5-Luc reporter, consistent with the notion that NF-B recruitment was functionally required for activation-dependent fas promoter induction. The critical requirement for NF-B recruitment was additionally verified in Jurkat cells overexpressing wild-type IB-␣. The overexpression of IB-␣, a natural inhibitor of NF-B translocation, has been shown to effectively block B-dependent transactivation (31, 32) . As shown in Fig.  5B , P/I-activated Jurkat cells transiently transfected with the ⌬5-Luc reporter and RsV-IB-␣ expression plasmid showed a dose-dependent decrease in fas promoter activity with increasing IB-␣ concentration. Taken together, these results strongly support the premise that NF-B translocation is essential for activation-dependent fas promoter induction.
The B-like motif at ؊295 to ؊286 controls activationdependent fas promoter responses. While previous experiments indicated that NF-B translocation was essential for fas promoter induction, the functional significance of the B element at positions Ϫ295 to Ϫ286 remained to be tested. To
Cold competition was performed with 1-h-activated Jurkat cell nuclear extracts with a 25-fold excess of consensus oligonucleotides for the transcription factors AP-1, NF-AT, wild-type probe B (W-T), or mutated probe B (Mut.) added prior to incubation with 32 P-labeled probe B (lanes 7 to 10). For NF-B and Sp1 competition, a 25-fold excess (lanes 11 and 13) and 100-fold excess (lanes 12 and 14) of consensus oligonucleotides were added to equivalent amounts of P/Iactivated nuclear extracts prior to addition of 32 determine the specific contribution of this B-Sp1 element, oligonucleotides were synthesized with the composite site altered (as underlined) (GGGCGTTCCC to TTTCGTTCCC) and with a mutagenized ⌬5 fas reporter construct generated by PCR. This construct was designated ⌬5M5.7-Luc. As a control, a second ⌬5 reporter construct containing the B site at Ϫ262 to Ϫ253 was also mutagenized (⌬5M5.8; GGGGCTTTTC to GCCYCTTTTC) and used in reporter assays. Jurkat cells transiently transfected with the wild-type ⌬5-Luc construct, ⌬5M5.7-Luc, or the ⌬5M5.8-Luc control were activated with P/I, and reporter activity was measured. Similar to previous experiments with the ⌬5 deletion constructs (Fig. 3B) , both wild-type ⌬5-Luc and ⌬5M5.8-Luc showed an approximate 15-fold induction following activation (Fig. 6 ). In contrast, ⌬5M5.7-Luc reporter activity increased only threefold after P/I treatment. These results document the functional contribution of the B-Sp1 site at positions Ϫ295 to Ϫ286, but not the consensus NF-B site at Ϫ262 to Ϫ243, in activation-dependent fas promoter induction. Interestingly, while ⌬5M5.7-Luc induction was significantly suppressed compared to that of the wild-type ⌬5-Luc construct (79.6% Ϯ 10.61%, respectively) P/I inducibility was not entirely abolished. Such findings suggest that an additional site or sites, perhaps in the region from Ϫ19 to Ϫ240 (compare Fig. 3B to Fig. 6 ), may be required for maximal fas promoter induction during T-cell activation.
To further verify the transcriptional contribution of the Ϫ295 to Ϫ286 B-Sp1 composite site, concatemer constructs containing multiple copies of this element upstream of a thymidine kinase promoter-driven luciferase reporter were generated (Fig. 2B) . Constructs containing none, two, four, or six copies of the B-Sp1 element were transiently transfected into Jurkat cells, and the reporter activity was measured after P/I activation (Fig. 6B) . As expected, the inducibility of the concatemer-reporter constructs increased with the number of the B-Sp1 elements multimerized, with six copies showing a Ͼ35-fold specific induction over that of the thymidine kinase promoter alone. As observed previously with the ⌬5-Luc construct (Fig. 5) , P/I inducibility of the B-Sp1 concatemers was specifically eliminated by inhibitors of NF-B translocation. Figures 6B and C show the effects of gliotoxin and IB-␣ overexpression on P/I inducibility of the B-Sp1-containing constructs. Furthermore, in cells transfected with six copies of the B-Sp1 element (/S6tk-Luc), basal reporter activity was fourfold higher in unstimulated Jurkat cells than that of the tk-Luc reporter alone, suggesting a possible enhancement of constitutive fas promoter regulation by multiple Sp1 sites. Taken together, these experiments confirm the functional significance of the B-Sp1 site at Ϫ295 to Ϫ286 in the control of activation-driven fas promoter induction.
DISCUSSION
In recent years, much attention has been focused on how the immune response is downregulated. Because self-reactive T cells are ineffectively deleted by negative selection in the thymus, the preservation of immune homeostasis requires selfregulatory mechanisms for the maintenance of tolerance and the control of excessive T-cell proliferation to foreign antigens in the periphery. Apoptosis is responsible for maintaining Tcell homeostasis by at least two mechanisms-AICD that occurs after TCR ligation by antigen and passive cell death that occurs in the absence of antigen or cytokine stimulation (1, 14, 26, 63) . The Fas-FasL-mediated pathway of apoptosis appears to be central in the regulation of peripheral tolerance, because mutations in either the receptor or the ligand can induce lymphadenopathy and autoimmune disease in mice and humans caused by defects in AICD and peripheral T-and B-cell deletion (18, 60, 65) . Fas is constitutively expressed on most cultured T cells, whereas freshly isolated, naïve (CD45RO ϩ ) peripheral blood T cells have little to no surface Fas. Early after T-cell activation, Fas is rapidly upregulated, but these Faspositive cells remain resistant to Fas-induced apoptosis (26, 37, 41, 44) . With the progression of an immune response, Faspositive T cells acquire sensitivity to Fas-induced killing (37, 44) . Although Fas upregulation is known to be a prerequisite for the elicitation of Fas-FasL-mediated AICD (1, 14, 26) , the molecular mechanisms underlying this process have not been well investigated. In this report, we have identified the imme- diate transcriptional events and cis-acting elements required for activation-induced fas expression in the human Jurkat cell line. Using transient transfection reporter assays, we have localized a 47-bp sequence (Ϫ306 to Ϫ260) upstream of the translational start site that confers P/I inducibility of the fas promoter (Fig. 3B) . Within this region, a critical 10-bp enhancer (Ϫ295 to Ϫ286) was shown to bind Sp1 during basal transcription expression and NF-B p50-p65 heterodimers after P/I activation (Fig. 4) . When binding of NF-B was inhibited by the blockade of B translocation or mutagenesis of the B-Sp1 site, activation-dependent Fas upregulation was lost. Our findings provide the first molecular evidence for differential control of constitutive and inducible Fas expression and suggest an intervention strategy for inducible Fas upregulation.
Sp1 is a zinc-finger transcription factor constitutively expressed in a variety of cell types that binds the GC-rich consensus sequences (KGGGCGGRRY or KRGGCGKRRY) present in many cellular and viral promoters. The N terminus of Sp1 contains glutamine-and serine/threonine-rich domains required for transactivation, while the C terminus is involved in synergistic activation and interaction with other transcription factors (12) . Although Sp1 has been shown to independently initiate transcription in TATA-less promoters (reviewed in reference 3), it can also form homo-or heteromultimeric complexes to transactivate a number of disparate promoters, including interleukin 2, VCAM-1, and the HIV LTR (42, 50, 56) . Several lines of circumstantial evidence suggest that Sp1 may be involved in basal fas transcription. First, sequences proximal to the fas translational start site have a relatively high GC content (61% between positions Ϫ590 and Ϫ1) and an absence of conventional TATA and CAAT boxes (5), typical of a subclass of polymerase II-dependent promoters controlled by the interactions of the glutamine-rich activation domains of Sp1 with TFIID components (9) . Second, the TATA-less, GC-rich area of the fas promoter (Ϫ590 to Ϫ1) has been shown to be Multimerized constructs were cotransfected with 5 g of either RsV-IB␣ or vector-only expression plasmids before activation with P/I as described above. Extracts were taken for luciferase measurements, and relative inhibition is calculated as the percentage of P/I-induced luciferase activity of the corresponding reporter constructs. functional in analyses of transcriptional start sites (5) . Third, the TATA-less ⌬5 fas promoter construct was sufficient in driving basal transcription. Fourth, Sp1 bound to the B-Sp1 site at positions Ϫ295 to Ϫ286 in resting, but not activated, Jurkat cell extracts (data not shown). Finally, multimers of the B-Sp1 element at positions Ϫ295 to Ϫ286 showed increase basal transcription in Jurkat cells (Fig. 6B) . Although Sp1 may be involved in the control of fas transcription in resting Jurkat cells, it is likely that multiple Sp1 binding elements are required for optimal basal levels of Fas expression. In this regard, site-directed mutagenesis of the B-Sp1 site at Ϫ295 to Ϫ286 alone inhibited basal fas transcription by ϳ20%, while disruption of a second consensus Sp1 site at Ϫ140 to Ϫ131 repressed basal fas transcription by greater than 50% (data not shown).
Nuclear translocation of the NF-B-Rel transcription factor family occurs in T lymphocytes in response to TCR engagement (reviewed in reference 20). The prototypic form of NF-B is a heterodimer complex containing NF-B1-p50 or NF-B2-p52 in combination with a transactivating subunit such as c-Rel or RelA (p65) (reviewed in reference 64). Each NF-B-Rel family member contains a conserved N-terminal region responsible for decameric DNA binding, dimerization, and IB interaction; NF-B-responsive genes are transactivated by the C-terminal domain of dimeric NF-B-Rel family members. In resting T lymphocytes, various NF-B subunits are sequestered in the cytoplasm by virtue of their association with by the IB family of inhibitors (IB␣, IB␤, IBε, IB␥, and bcl-3), which masks their nuclear localization signal (reviewed in reference 64). During T-cell activation, intracellular signaling triggers multiple kinase pathways that converge in the activation of the IB kinase complex (IKK); IKK then phosphorylates IB␣ or IB␤ at conserved serines, resulting in the targeting of the B inhibitor for ubiquitin-proteasome-dependent destruction and permitting the nuclear translocation of NF-B (10). Binding sites for NF-B have been found in numerous genes involved in effector T-cell function, including those regulating cytokine production, cell adhesion molecules, and apoptosis. In this report, we have demonstrated that NF-B p50-p65 mediates inducible fas promoter activation in T lymphocytes at Ϫ460 to Ϫ240 and confers the majority of P/I responsiveness at a single, noncanonical B-Sp1-like motif (GGGCGTTCCC) located at Ϫ295 to Ϫ286. Interestingly, although two consensus NF-B sites as well as GAS, NF-ATp, AP-2, and Egr-1 sites are also present within this region, the contribution of these elements to either basal or inducible fas promoter induction in Jurkat cells was insignificant (Fig. 3) . Notably, however, such motifs may be functional in other cell types, because Egr-1 binding at Ϫ371 to Ϫ338 has been reported to repress fas transcription during B-cell activation (16) .
The mutually exclusive binding of either Sp1 or NF-B to the novel composite B-Sp1 site at Ϫ295 to Ϫ286 in the fas promoter differs from the previously described cross-coupling of NF-B with the transcription factor AP-1 or HMG I(Y) (58, 62) . Our observations are not unexpected, however, in light of reports documenting the functional interference of Sp1 and NF-B at selected NF-B binding sites (21) and crystallographic data showing that Sp1 and p50 homodimers both interact with DNA at the major groove (19, 38, 49) . In this report, we provide multiple lines of evidence that NF-B p50-p65 heterodimers displace Sp1 at the composite B-Sp1 site to drive activation-dependent interaction of the fas promoter. First, P/I-dependent promoter induction requires the sequences between Ϫ306 and Ϫ260 containing the B-Sp1 site (Fig. 3B) . Second, NF-B p50-65 heterodimers bound to this region of the fas promoter only during activation (Fig. 4A and  B) . Third, recombinant NF-B p50 displaced Sp1 binding to the B-Sp1 site in a dose-dependent manner (Fig. 4C) . Fourth, recruitment of NF-B to the fas promoter region at Ϫ295 to Ϫ286 was required for activation-dependent fas promoter induction, but not for basal activity (Fig. 5) . Fifth, specific mutagenesis of the NF-B site at Ϫ295 to Ϫ286 significantly diminished P/I-dependent fas promoter induction (Fig. 6A) . Finally, multimers of the B-Sp1 site juxtaposed to a minimal thymidine kinase promoter were functionally responsive to P/I stimulation in a dose-dependent manner (Fig. 6B) . In further support of our observations that NF-B is critically required for activation-induced fas upregulation, several inducers of NF-B, including UV irradiation, hypoxia, cytokines, and TNF, have been reported to rapidly upregulate Fas (24, 44, 61) . It is interesting to speculate that Sp1, bound to the B-Sp1 site during basal transcription, may facilitate rapid activationinduced fas promoter responsiveness mediated by NF-B translocation as a consequence of its role in DNA bending (57) .
If Fas is similarly regulated in Jurkat and fresh T cells, our findings may be relevant to HIV pathogenesis, in which increased Fas expression and sensitivity to FasL-induced apoptosis have been reported during infection and disease progression (2, 4, 27) . Interestingly, both HIV-1 binding and gp120-mediated CD4 cross-linking can induce NF-B (8). Because NF-B can drive both HIV-1 expression (50) and fas upregulation, inhibition of NF-B may be one major strategy to suppress both viral replication (31) and premature execution of the AICD pathway resulting in T-cell depletion. Indeed, inhibitors of NF-B may also effectively repress Fas-driven apoptosis in response to metabolic stress, genotoxic insults, and viral infections.
Although our studies clearly demonstrate a critical role for NF-B in fas upregulation, other transcriptional or posttranscriptional processes may also be operative, depending upon the cell type and cellular microenvironment. For example, the proline-, glutamine-, and histidine-rich protein TDAG51 has been reported to be critical for Fas mRNA induction after TCR engagement (47) . Our laboratory has demonstrated that wild-type p53 can upregulate fas expression in both hematopoietic and nonhematopoietic cells (45) . Taken with our current observations, it is plausible that p53 may act with NF-B to increase fas transcription, particularly under conditions of metabolic and genotoxic stress. mRNA stability may also regulate fas expression. In this regard, the 3Ј untranslated region of fas contains several AU-rich elements reported to induce selective mRNA degradation (29, 55) . Given the potent biological function of the Fas protein, multiple levels of gene regulation involving both cis-acting transcription and mRNA stability would not be unexpected.
In summary, our studies have identified a novel B-Sp1 enhancer motif in the fas promoter in which NF-B p50-p65 dimers bind to drive activation-dependent Fas upregulation in T cells. The critical involvement of NF-B further underscores the importance of this transcription factor in immunohomeostasis and prompts consideration for strategies aimed toward its manipulation in various pathophysiological states involving inappropriate Fas and FasL interactions, including malignant disease, autoimmunity, and AIDS.
